Stay updated with breaking news from About Emitbio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
At-Home Treatment Saves Lives and Dollars4th Peer Reviewed Manuscript Supports Utility of RD-X19 Home Treatment DURHAM, N.C., July 20, 2022 /PRNew...
Share this article Share this article DURHAM, N.C., Feb. 17, 2021 /PRNewswire/ -- EmitBio Inc., today announced statistically significant efficacy results from its randomized, placebo-controlled, double-blind Phase I/II clinical trial. The study was conducted with an investigational treatment device* that directs precise wavelengths of safe, visible light targeted to the back of the throat and surrounding tissues. The device is designed for self-treatment of COVID-19 in an at-home setting. EmitBio™ achieved clinically and statistically significant results in both the reduction of SARS-CoV...